These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2051319)

  • 1. Interaction of prostaglandin E1 with alpha-cyclodextrin in aqueous systems: stability of the inclusion complex.
    Wiese M; Cordes HP; Chi H; Seydel JK; Backensfeld T; Müller BW
    J Pharm Sci; 1991 Feb; 80(2):153-6. PubMed ID: 2051319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H-nuclear magnetic resonance (NMR) studies on the inclusion complex of prostaglandin E1 (PGE1) with alpha-cyclodextrin.
    Steffan B; Fischer W; Cordes G; Habon I; Müller R
    Pharm Res; 1992 Apr; 9(4):575-7. PubMed ID: 1495905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the molecular complexation constant between alprostadil and alpha-cyclodextrin by conductometry: implications for a freeze-dried formulation.
    Sheehy PM; Ramstad T
    J Pharm Biomed Anal; 2005 Oct; 39(5):877-85. PubMed ID: 16126357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ternary inclusion complex formation and stabilization of limaprost, a prostaglandin E1 derivative, in the presence of α- and β-cyclodextrins in the solid state.
    Inoue Y; Iohara D; Sekiya N; Yamamoto M; Ishida H; Sakiyama Y; Hirayama F; Arima H; Uekama K
    Int J Pharm; 2016 Jul; 509(1-2):338-347. PubMed ID: 27286633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination by NMR of the binding constant for the molecular complex between alprostadil and alpha-cyclodextrin. Implications for a freeze-dried formulation.
    Ramstad T; Hadden CE; Martin GE; Speaker SM; Teagarden DL; Thamann TJ
    Int J Pharm; 2005 May; 296(1-2):55-63. PubMed ID: 15885455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the binding constant between alprostadil and alpha-cyclodextrin by capillary electrophoresis: implications for a freeze-dried formulation.
    Schipper BR; Ramstad T
    J Pharm Sci; 2005 Jul; 94(7):1528-37. PubMed ID: 15920771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The complexation of prostaglandin E1 with hydroxylpropyl-beta-cyclodextrin in aqueous solution].
    Gu FG; Cui FD; Gao YL
    Yao Xue Xue Bao; 2004 Sep; 39(9):742-6. PubMed ID: 15606027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complex of fenbufen with beta-cyclodextrin.
    Bratu I; Gavira-Vallejo JM; Hernanz A; Bogdan M; Bora G
    Biopolymers; 2004 Mar; 73(4):451-6. PubMed ID: 14991662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of the ternary inclusion complex of limaprost with α- and β-cyclodextrins in aqueous solution.
    Inoue Y; Sekiya N; Yamamoto M; Iohara D; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2015; 63(5):318-25. PubMed ID: 25948325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution.
    Bettinetti G; Melani F; Mura P; Monnanni R; Giordano F
    J Pharm Sci; 1991 Dec; 80(12):1162-70. PubMed ID: 1815076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on experimental immune complex nephritis (3). Therapeutic effect of prostaglandin E1 alpha-cyclodextrin host molecule (PGE1 . CD) on serum sickness nephritis in rats.
    Nagamatsu T; Saitoh N; Suzuki Y; Ikuta K; Aoki S
    Jpn J Pharmacol; 1984 Aug; 35(4):407-14. PubMed ID: 6239050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes.
    Kopecký F; Vojteková M; Kaclík P; Demko M; Bieliková Z
    J Pharm Pharmacol; 2004 May; 56(5):581-7. PubMed ID: 15142334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complexation of the sunscreen agent 2-ethylhexyl-p-dimethylaminobenzoate with hydroxypropyl-beta-cyclodextrin: effect on photostability.
    Scalia S; Villani S; Casolari A
    J Pharm Pharmacol; 1999 Dec; 51(12):1367-74. PubMed ID: 10678490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of alpha-cyclodextrin induced hemolysis. 2. A study of the factors controlling the association with serine-, ethanolamine-, and choline-phospholipids.
    Debouzy JC; Fauvelle F; Crouzy S; Girault L; Chapron Y; Göschl M; Gadelle A
    J Pharm Sci; 1998 Jan; 87(1):59-66. PubMed ID: 9452969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic analysis of the binding of a hepatoprotectant drug, thioctic acid, by beta-cyclodextrin.
    Junquera E; Aicart E
    J Pharm Sci; 1999 Jun; 88(6):626-31. PubMed ID: 10350499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the supramolecular systems of 5-(2-hydroxy phenyl)-10,15,20-tris (4-methoxy phenyl) porphyrin with cyclodextrins.
    Kong LH; Guo YJ; Li XX; Pan JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Mar; 66(3):594-8. PubMed ID: 16859961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of prostaglandin E1.alpha-cyclodextrin (PGE1.CD) on dimethylnitrosamine-induced acute liver damage in rats].
    Suzuki A; Hagino M; Yasuda N; Sagawa K; Terawaki T; Ogawa M; Kondo K; Hamanaka N; Tanaka M; Aze Y
    Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):221-9. PubMed ID: 7774859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of stability and dissolution of prostaglandin E1 by maltosyl-beta-cyclodextrin in lyophilized formulation.
    Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):747-51. PubMed ID: 1611688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.